Results 21 to 30 of about 802,496 (169)

Transesophageal Echocardiography for Mitral Valve Transcatheter Edge-to-Edge Repair

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
Transcatheter edge-to-edge repair (TEER) has emerged as a viable treatment option for patients with degenerative or functional severe mitral regurgitation (MR) who are at high risk for mitral valve surgery but have mitral valve anatomy suitable for TEER.
Nitin J Burkule, Manish Bansal
doaj   +1 more source

Transapical Transcatheter Mitral Valve Implantation with the Tendyne Valve: The Swiss Experience

, 2023
BACKGROUND  The aim of this study was to report outcomes of all patients undergoing transcatheter mitral valve implantation with the Tendyne Mitral Valve System (Tendyne) in Switzerland.
David Reineke, Nucera, Maria, Praz, Fabien, Jules Miazza, Miazza, Jules, Maria Nucera, Christoph Kaiser, Fabien Praz, Matthias Siepe, Siepe, Matthias, Reineke, David, Oliver Reuthebuch, Reuthebuch, Oliver, Kaiser, Christoph   +13 more
core   +1 more source

Transcatheter Mitral Valve Replacement and Thrombosis: A Review

Frontiers in Cardiovascular Medicine, 2021
Mitral regurgitation is the most prevalent form of moderate or severe valve disease in developed countries. Surgery represents the standard of care for symptomatic patients with severe mitral regurgitation, but up to 50% of patients are denied surgery ...
Guido Ascione, Paolo Denti
doaj   +1 more source

Translational research in the new era of percutaneous mitral valve interventions

REC: Interventional Cardiology (English Ed.), 2021
Mitral regurgitation (MR) is one of the most prevalent valvular heart diseases in the world.1 Although surgical mitral valve replacement has shown to improve clinical outcomes in patients with severe primary MR, surgery is still being denied in a ...
Juan F. Granada
doaj   +1 more source

The role of transcatheter mitral valve leaflet approximation for the treatment of secondary mitral regurgitation: current status and future prospects.

, 2021
Introduction: Secondary mitral regurgitation (SMR) is one of the most common valvulopathies and is associated with poor prognosis. Over the past years, medical management and mitral valve repair options have rapidly evolved offering new opportunities for
Brugger, Nicolas, Windecker, Stephan, Corpataux, Noé, Praz, Fabien, Reineke, David, Vahanian, Alec, Hunziker, Lukas   +6 more
core   +1 more source

Racial Disparities in the Utilization and Outcomes of Structural Heart Disease Interventions in the United States

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Data on race‐ and ethnicity‐based disparities in the utilization and outcomes of structural heart disease interventions in the United States are scarce.
Mohamad Alkhouli, Fahad Alqahtani, David R. Holmes, Chalak Berzingi   +3 more
doaj   +1 more source

Debate: Intervention on the mitral and the tricuspid valves. Perspective from interventional cardiology

REC: Interventional Cardiology (English Ed.), 2021
QUESTION: What is the current status of percutaneous coronary interventions to treat functional mitral regurgitation (MR)? ANSWER: To this date, transcatheter mitral valve repair therapies are backed by the highest scientific evidence.
Dabit Arzamendi
doaj   +1 more source

Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives [PDF]

Reviews in Cardiovascular Medicine, 2021
Transcatheter mitral valve repair with MitraClip has emerged as a possible therapeutic option for patients with severe mitral regurgitation (MR) with high risk for surgical valve repair. MitraClip intervention has demonstrated to improve haemodynamics
Alessandro Mandurino-Mirizzi, Lorenzo Tua, Luca Arzuffi, Andrea Demarchi, Alberto Somaschini, Georgios Tournas, Gabriele Crimi, Emmanuel Androulakis, Alexandros Briasoulis, Stefano Cornara   +9 more
doaj   +1 more source

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

Surgical antegrade transcatheter mitral valve implantation for symptomatic mitral valve disease and heavily calcified annulus. [PDF]

, 2016
Surgical techniques for the treatment of mitral valve disease (MVD) have continuously evolved; however, anatomical details like severe annular calcification remain challenging and require sophisticated surgical strategies. Among patients with symptomatic
Langhammer, Bettina Michaela, Windecker, Stephan, Huber, Christoph, Carrel, Thierry, Langhammer, Bettina   +4 more
core   +2 more sources